The alterations observed demonstrate that the underlying dysregulations of the immune system go much deeper than the commonly recognized neutropenia and affect multiple populations across all arms of the immune system, likely influencing the clinical manifestations of GSD1b such as recurrent infections and IBD. Here, SLC37A4 is linked to inflammatory bowel disease.